Live feed
Filing
SC 13G/A
SC 13G/A0001535610-18-000019·Outlook Therapeutics, Inc.
Schedule 13G ownership disclosure
Oncobiologics, Inc.
Security class unavailable · CUSIP: 68235M105
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,401,787
- Percent of class
- 9.4100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-18-000019
- Form type
- SC 13G/A
- Filer
- Outlook Therapeutics, Inc.
- CIK
- CIK 1649989
- Filed
- Jan 05, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership